Oxular’s Chief Scientific Officer, Ron Yamamoto, shared an overview of Oxular’s drug delivery formulations at the OIS Drug Delivery meeting.
You can watch the entire talk below, to find out more about our long-lasting drug formulations – including a first look at our micelle technology designed for targeted, local delivery of chemotherapeutic agents in the suprachoroidal space.